Effect of Radiofrequency Catheter Ablation for Atrial Fibrillation on Morbidity and Mortality
Authors:
- Chia-Hsuin ChangCCChia-Hsuin Chang
- Jou-Wei LinJLJou-Wei Lin
- Fu-Chun ChiuFCFu-Chun Chiu
- James L. CaffreyJCJames L. Caffrey
- Li-Chiu WuLWLi-Chiu Wu
- Mei-Shu LaiMLMei-Shu Lai
- 1 February 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 7 (1) , 76-82
Abstract
Background—: This study examined the effect of radiofrequency catheter ablation (RFA) on reducing morbidity and mortality among patients with atrial fibrillation (AF). Methods and Results—: A retrospective cohort of patients with AF without prior stroke or heart failure (HF) who underwent RFA between 2003 and 2009 was identified using Taiwan’s National Health Insurance claims database. Outpatients with AF who met the same enrollment criteria but did not receive RFA were matched (≤1:20) by hospitals and dates to serve as controls. Outcomes of interest were death, stroke, or hospitalization for HF. A proportional hazard Cox regression model adjusted by propensity scores (based on age, sex, hypertension, diabetes mellitus, comorbidities, medications, and medical resource utilization) was applied to estimate the hazard ratio and 95% confidence interval. A total of 846 patients with AF who received RFA and 11 324 matched AF controls were included, with a mean follow-up of 3.74 and 3.96 years, respectively. RFA was associated with a lower hazard for stroke (hazard ratio, 0.57; 95% confidence interval, 0.35–0.94; P =0.026). The reduction in the hazard for death and HF did not reach statistical significance (hazard ratio, 0.88; 95% confidence interval, 0.62–1.23; P =0.451 and hazard ratio, 0.78; 95% confidence interval, 0.55–1.12; P =0.185, respectively). Additional analysis using death as a competing risk showed similar results for stroke and HF. Conclusions—: RFA did not reduce mortality or hospitalization for HF during the immediate 3.5-year follow-up. Although a beneficial effect on stroke prevention associated with RFA was suggested, residual confounding attributable to unmeasured factors remains a concern.Keywords
This publication has 29 references indexed in Scilit:
- Health Outcomes With Catheter Ablation or Antiarrhythmic Drug Therapy in Atrial FibrillationCirculation: Cardiovascular Quality and Outcomes, 2012
- Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial FibrillationJACC, 2012
- Atrial Fibrillation PathophysiologyCirculation, 2011
- Improvements in Symptoms and Quality of Life in Patients With Paroxysmal Atrial Fibrillation Treated With Radiofrequency Catheter Ablation Versus Antiarrhythmic DrugsCirculation: Cardiovascular Quality and Outcomes, 2010
- Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial FlutterCirculation, 2009
- Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation—A nationwide descriptive study in TaiwanClinical Therapeutics, 2008
- Coding of Stroke and Stroke Risk Factors Using International Classification of Diseases , Revisions 9 and 10Stroke, 2005
- Evolution of non-pharmacological curative therapy for atrial fibrillationInternational Journal of Cardiology, 2003
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal DistributionsJournal of the American Statistical Association, 1989